私募股权投资眼科医疗机构：它如何影响临床研究？
Private equity ownership of ophthalmology practices: how does it impact clinical research?
机构信息
Retinal Consultants of Sacramento, Sacramento, California, USA.
出版信息
Curr Opin Ophthalmol. 2022 Sep 1;33(5):368-372. doi: 10.1097/ICU.0000000000000873. Epub 2022 Jul 25.
PURPOSE OF REVIEW
To explore the impact of private equity ownership of ophthalmology practices on the success of their clinical research programs.
RECENT FINDINGS
Private equity partnership in the clinical research space has been steadily occurring over the past decades. In addition to contract research organizations, private equity groups have also consolidated multiple independent clinical research networks. By investing in an increasing number of retina practices, one private equity group is attempting to create a synergistic relationship between clinical practice and clinical research with the goal of supporting a larger, more robust clinical research network.
SUMMARY
Although there are physician concerns about the potential deleterious effects of private equity ownership on clinical research capabilities, private equity support has the potential to be an important stimulus for clinical research growth.
VIDEO ABSTRACT
目的综述：探讨眼科医疗机构的私募股权投资对其临床研究项目成功的影响。
最近发现：过去几十年来，私募股权投资在临床研究领域一直稳步增长。除了合同研究组织，私募股权集团还整合了多个独立的临床研究网络。通过投资越来越多的视网膜实践，一个私募股权集团试图在临床实践和临床研究之间建立协同关系，目的是支持一个更大、更强大的临床研究网络。
总结：尽管医生们担心私募股权所有权对临床研究能力可能产生的不利影响，但私募股权的支持有可能成为临床研究增长的重要动力。
视频摘要：[视频链接]
Zotero 插件